Home NDC 70934-079 SUPRAX
Product NDC 70934-079
11-digit product format 709340079
Labeler code 70934
Product ID 70934-079_9abb3209-588b-fdba-e053-2a95a90ae15b
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name cefixime
Dosage form CAPSULE
Route ORAL
Labeler Denton Pharma, Inc. DBA Northwind Pharmaceuticals
Application NDA203195
Marketing category NDA
Marketing start 2018-02-09
Marketing end 0000-00-00
Substance CEFIXIME
Active strength 400 mg/1
Pharmacologic classes Cephalosporin Antibacterial [EPC],Cephalosporins [CS]
NDC exclude flag No
Listing certified through 2020-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 38 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 70934-079-01 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 70934-079-01 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 70934-079-01 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 70934-079-01 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 70934-079-01 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 70934-079-01 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 70934-079-01 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 70934-079-01 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 70934-079-01 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 70934-079-01 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 70934-079-01 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 70934-079-01 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 excluded product product 8af77b9d5b6f…d9bbb34c5368…2024-05-28 21:12 UTC · source 2024-05-28 excluded package package 70934-079-01 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 excluded product product 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 70934-079-01 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 excluded product product 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 70934-079-01 1332a3947898…d4bfe170f9cd…2022-08-30 03:57 UTC · source 2022-08-29 excluded product product fb8cb913e6d1…eb8c232b6be0…2022-08-30 03:57 UTC · source 2022-08-29 excluded package package 70934-079-01 fb8cb913e6d1…eb8c232b6be0…2022-04-09 23:13 UTC · source 2022-04-08 excluded product product 86f5da6cb304…a595104c45d7…2022-04-09 23:13 UTC · source 2022-04-08 excluded package package 70934-079-01 86f5da6cb304…a595104c45d7…2022-04-04 05:40 UTC · source 2022-04-01 excluded product product bd6a592717d7…303034d00443…2022-04-04 05:40 UTC · source 2022-04-01 excluded package package 70934-079-01 bd6a592717d7…303034d00443…2021-12-27 23:28 UTC · source 2021-12-27 excluded product product 8dfbde2a14a4…c9ff85d89658…2021-12-27 23:28 UTC · source 2021-12-27 excluded package package 70934-079-01 8dfbde2a14a4…c9ff85d89658…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N203195-001 SUPRAX CEFIXIME 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL AB RLD, RS 2012-06-01
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N203195-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 42 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N203195-001 SUPRAX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL AB RLD, RS 2012-06-01 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N203195-001 SUPRAX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL AB RLD, RS 2012-06-01 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N203195-001 SUPRAX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL AB RLD, RS 2012-06-01 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N203195-001 SUPRAX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL AB RLD, RS 2012-06-01 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N203195-001 SUPRAX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL AB RLD, RS 2012-06-01 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N203195-001 SUPRAX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL AB RLD, RS 2012-06-01 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N203195-001 SUPRAX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL AB RLD, RS 2012-06-01 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N203195-001 SUPRAX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL AB RLD, RS 2012-06-01 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N203195-001 SUPRAX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL AB RLD, RS 2012-06-01 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N203195-001 SUPRAX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL AB RLD, RS 2012-06-01 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N203195-001 SUPRAX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL AB RLD, RS 2012-06-01 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N203195-001 SUPRAX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL AB RLD, RS 2012-06-01 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N203195-001 SUPRAX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL AB RLD, RS 2012-06-01 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N203195-001 SUPRAX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL AB RLD, RS 2012-06-01 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N203195-001 SUPRAX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL AB RLD, RS 2012-06-01 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N203195-001 SUPRAX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2012-06-01 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N203195-001 SUPRAX 400MG CAPSULE / ORAL RLD 2012-06-01 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N203195-001 SUPRAX 400MG CAPSULE / ORAL RLD 2012-06-01 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N203195-001 SUPRAX 400MG CAPSULE / ORAL AB RLD, RS 2012-06-01 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N203195-001 SUPRAX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2012-06-01 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N203195-001 SUPRAX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** CAPSULE / ORAL RLD 2012-06-01 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N203195-001 SUPRAX 400MG CAPSULE / ORAL RLD 2012-06-01 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N203195-001 SUPRAX 400MG CAPSULE / ORAL RLD 2012-06-01 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N203195-001 SUPRAX 400MG CAPSULE / ORAL RLD 2012-06-01 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N203195-001 SUPRAX 400MG CAPSULE / ORAL RLD 2012-06-01 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N203195-001 SUPRAX 400MG CAPSULE / ORAL AB RLD, RS 2012-06-01 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N203195-001 SUPRAX 400MG CAPSULE / ORAL AB RLD, RS 2012-06-01 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N203195-001 SUPRAX 400MG CAPSULE / ORAL AB RLD, RS 2012-06-01 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N203195-001 SUPRAX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL AB RLD, RS 2012-06-01 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N203195-001 SUPRAX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL AB RLD, RS 2012-06-01 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N203195-001 SUPRAX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL AB RLD, RS 2012-06-01 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N203195-001 SUPRAX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL AB RLD, RS 2012-06-01 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N203195-001 SUPRAX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL AB RLD, RS 2012-06-01 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N203195-001 SUPRAX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL AB RLD, RS 2012-06-01 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N203195-001 SUPRAX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL AB RLD, RS 2012-06-01 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N203195-001 SUPRAX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL AB RLD, RS 2012-06-01 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N203195-001 SUPRAX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL AB RLD, RS 2012-06-01 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N203195-001 SUPRAX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL AB RLD, RS 2012-06-01 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N203195-001 SUPRAX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL AB RLD, RS 2012-06-01 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N203195-001 SUPRAX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL AB RLD, RS 2012-06-01 e64feba35796…
Observed Orange Book normalized TE history# DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 70934-079-01 SUPRAX 1 in 1 BOTTLE, PLASTIC CAPSULE 1 2
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 70934-079 SUPRAX (CEFIXIME) CAPSULE [DENTON PHARMA, INC. DBA NORTHWIND PHARMACEUTICALS] 2 Legacy NDC, 1 package rows 20191228_655a59ba-08e9-51d4-e053-2991aa0aef34.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Status 70934-079-01 70934007901 1 in 1 BOTTLE, PLASTIC Historical